PHRM — Pharmather Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- CA$18.15m
- CA$16.59m
- 52
- 12
- 54
- 33
Annual cashflow statement for Pharmather Holdings, fiscal year end - May 31st, CAD millions except per share, conversion factor applied.
2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | 2024 May 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.283 | 2.66 | -4.01 | -6.42 | -3.12 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.02 | -2.11 | 0.507 | 2.63 | 0.215 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.018 | 0.186 | 0.176 | 0.546 | -0.622 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Cash from Operating Activities | -0.245 | 0.922 | -3.51 | -3.24 | -3.52 |
| Capital Expenditures | — | -0.004 | 0 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 0.219 | 0 | — | -0.3 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | 0.215 | 0 | — | -0.3 |
| Financing Cash Flow Items | -0.038 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 0.451 | 1.25 | 9.89 | 0 | 0.035 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.206 | 2.39 | 6.38 | -3.24 | -3.79 |